Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
22.55
Price to sales ratio
0.27
Dividends per share
3.17
Dividend yield %
0.37

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
281
COR
Cencora, Inc. Common Stock
302.26 USD-1.27%-0.21%+7.04%-8.69%58.81 B USD
296
CAH
Cardinal Health, Inc. Common Stock
230.02 USD-1.56%-3.57%+1.78%+41.06%53.87 B USD
919
HSIC
Henry Schein, Inc. - Common Stock
86.91 USD+1.31%-0.07%+6.78%+22.89%9.90 B USD
2584
AHG
Akso Health Group - American Depositary Shares
1.52 USD+2.70%+0.66%+33.33%-13.64%838.83 M USD

Frequently asked questions about McKesson Corporation Common Stock

What is the McKesson Corporation Common Stock stock price today?

The current price of McKesson Corporation Common Stock (MCK) is 802.68. Over the past 24 hours, the stock has changed by -1.21%. Follow the MCK chart for real-time price dynamics.

What is the stock ticker of McKesson Corporation Common Stock?

McKesson Corporation Common Stock trades under the ticker MCK. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is McKesson Corporation Common Stock stock going up?

MCK has changed by -0.24% over the last week, +2.52% over the last month, and +0.02% over the last year. Review the chart to see whether the current move is part of a broader trend.

Does McKesson Corporation Common Stock release financial reports?

Yes. You can track McKesson Corporation Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

What was McKesson Corporation Common Stock net income for the last quarter?

McKesson Corporation Common Stock reported net income of 1.68 B for the last quarter. The previous quarter showed 1.19 B, which means net income changed by +41.82%.

How many employees does McKesson Corporation Common Stock have?

As of the latest available data, McKesson Corporation Common Stock has 43 K employees. Workforce size can provide additional context about the company's scale and operations.

What is McKesson Corporation Common Stock EBITDA?

McKesson Corporation Common Stock EBITDA is 2.35 B, and its EBITDA margin is 2.44%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy McKesson Corporation Common Stock stock?

You can buy McKesson Corporation Common Stock (MCK) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in McKesson Corporation Common Stock stock?

Investing in McKesson Corporation Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MCK chart and related analysis on metatrader.com as part of your research.

McKesson Corporation Common Stock

McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK". McKesson provides extensive network of infrastructure for the healthcare industry and was an early adopter of technologies, including barcode scanning for distribution, pharmacy robotics, and RFID tags. The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States. Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the US government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over a billion doses.

News